Worldwide Viral Antigens Industry to 2027 - Increased Acceptance of Viral Antigens in Vaccine Development is Driving Growth

Dublin, Jan. 28, 2021 (GLOBE NEWSWIRE) -- The "Viral Antigens Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Component, Technique, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global viral antigens market was valued at US$ 101.41 million in 2019 and is projected to reach US$ 236.80 million by 2027; it is expected to grow at a CAGR of 11.0% during 2020-2027. The report highlights trends prevailing in the global viral antigens market, and drivers and restraints pertaining to the market growth.

The growth of the viral antigens market is attributed to the increased acceptance of viral antigens in vaccine development, and advancements in image analysis software and informatics platforms for viral antigen detection. Further, the emerging markets offer lucrative opportunities to the global viral antigens market players. However, the high cost of vaccine development hinders the market growth.

On the basis of component, the viral antigens market is segmented into Influenza Viral Antigens, coronavirus antigens, Zika virus antigens, Ebola virus antigens, Dengue virus antigens, Herpes Simplex Virus (HSV) antigens, rotavirus viral antigens, Hepatitis A-E virus antigens, measles virus antigens, mumps/parotitis virus antigens, and others.

In 2019, the coronavirus antigens segment accounted for the largest share of the market. The growth of the market for this segment is attributed to the rising number of product launches and increasing innovations in corona viral antigens.

Microbix Biosystems, BIO-RAD LABORATORIES INC., Creative Diagnostics, Aalto Bio Reagents Ltd., Advanced Biotechnologies Inc., Prospec-Tany Technogene Ltd., ACROBiosystems., MERIDIAN BIOSCIENCE, INC., Rekom Biotech S.L, and LGC Limited are among the key players operating in the viral antigens market. These companies focus on partnerships, product launches, and collaborations, among other business strategies, to sustain their market positions. For instance, in May 2020, Bio-Rad Laboratories received the EUA approval from the US FDA for its SARS-CoV-2 Total Ab test, which is a blood-based assay to identify all the antibodies developed by human body in response to the novel coronavirus SARS-CoV-2.

The report segments the global Viral Antigens market as follows:

By Component

• Influenza Viral Antigens

• Coronavirus Antigens

• Zika Virus Antigens

• Ebola Virus Antigens

• Dengue Virus Antigens

• Herpes Simplex Virus (HSV) Antigens

• Rotavirus Viral Antigens

• Hepatitis A-E Virus Antigens

• Measles Virus Antigens

• Mumps/Parotitis Virus Antigens

• Others

By Technique

• ELISA

• Immunoassay

• Hemagglutination

• Radioimmunoassay (RIA)

• Immunoperoxidase Staining

• Immunofluorescence

• Others

By End User

• Hospitals

• Clinics

• Laboratories

• Diagnostic Centers

• Blood Banks

• Research Institutes

By Geography

• North America

• US

• Canada

• Mexico

• Europe

• France

• Germany

• Italy

• UK

• Russia

• Asia Pacific

• China

• India

• South Korea

• Japan

• Australia

• Middle East and Africa

• South Africa

• Saudi Arabia

• UAE

• South and Central America

• Brazil

• Argentina

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the viral antigens market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global viral antigens market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Viral Antigens Market - By Component
1.3.2 Global Viral Antigens Market - By Technique
1.3.3 Global Viral Antigens Market - By End User
1.3.4 Global Viral Antigens Market - By Geography

2. Viral Antigens Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Viral Antigens Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South & Central America
4.3 Expert Opinion

5. Viral Antigens Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increased Acceptance of Viral Antigens in Vaccine Development
5.1.2 Advancements in Image Analysis Software and Informatics Platforms for Viral Antigen Detection
5.2 Market Restraints
5.2.1 High Cost of Vaccine Development
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Growing Trend of Plant-Made Vaccine Antigens and Biopharmaceuticals
5.5 Impact Analysis

6. Viral Antigens Market - Global Analysis
6.1 Global Viral Antigens Market Revenue Forecast And Analysis
6.2 Global Viral Antigens Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Viral Antigens Market - By Component
7.1 Overview
7.2 Viral Antigens Market Share, by Component, 2019 and 2027 (%)
7.3 Influenza Viral Antigens
7.3.1 Overview
7.3.2 Influenza Viral Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.4 Coronavirus Antigens
7.4.1 Overview
7.4.2 Coronavirus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.5 Zika Virus Antigens
7.5.1 Overview
7.5.2 Zika Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.6 Ebola Virus Antigens
7.6.1 Overview
7.6.2 Ebola Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.7 Dengue Virus Antigens
7.7.1 Overview
7.7.2 Dengue Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.8 Herpes Simplex Virus (HSV) Viral Antigens
7.8.1 Overview
7.8.2 Herpes Simplex Virus (HSV) Viral Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.9 Rotavirus Viral Antigens
7.9.1 Overview
7.9.2 Rotavirus Viral Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.10 Hepatitis A-E Virus Antigens
7.10.1 Overview
7.10.2 Hepatitis A-E Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.11 Measles Virus Antigens
7.11.1 Overview
7.11.2 Measles Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.12 Mumps/Parotitis Virus Antigens
7.12.1 Overview
7.12.2 Mumps/Parotitis Virus Antigens: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)
7.13 Others
7.13.1 Overview
7.13.2 Others: Viral Antigens Market - Revenue and Forecast to 2027 (USD Million)

8. Viral Antigens Market Analysis - By Technique
8.1 Overview
8.2 Viral Antigens Market Revenue Share, by Technique (2019 and 2027)
8.3 ELISA
8.3.1 Overview
8.3.2 ELISA: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Immunoassay
8.4.1 Overview
8.4.2 Immunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Hemagglutination
8.5.1 Overview
8.5.2 Hemagglutination: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Radioimmunoassay (RIA)
8.6.1 Overview
8.6.2 Radioimmunoassay: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Immunoperoxidase Staining
8.7.1 Overview
8.7.2 Immunoperoxidase Staining: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.8 Immunofluorescence
8.8.1 Overview
8.8.2 Immunofluorescence: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)

9. Viral Antigens Market Analysis - By End User
9.1 Overview
9.2 Viral Antigens Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Laboratories
9.5.1 Overview
9.5.2 Laboratories: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Diagnostic Centres
9.6.1 Overview
9.6.2 Diagnostic Centres: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Blood Banks
9.7.1 Overview
9.7.2 Blood Banks: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Research Institutes
9.8.1 Overview
9.8.2 Research Institutes: Viral Antigens Market - Revenue and Forecast to 2027 (US$ Million)

10. Viral Antigens Market - Geographic Analysis
10.1 North America: Viral Antigens Market
10.2 Europe: Viral Antigens Market
10.3 Asia Pacific: Viral Antigens Market
10.4 Middle East & Africa: Viral Antigens Market
10.5 South and Central America: Viral Antigens Market

11. Impact of COVID-19 Pandemic on Global Viral Antigens Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe (EU): Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Viral Antigens Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Microbix Biosystems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BIO-RAD LABORATORIES INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Creative Diagnostics
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Aalto Bio Reagents Ltd.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Advanced Biotechnologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Prospec-Tany Technogene Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 ACROBiosystems.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Rekom Biotech S.L
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 LGC Limited.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/111m3p

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900